Production (Stage)
Inspire Medical Systems, Inc.
INSP
$143.21
-$2.74-1.88%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 2.99M | 35.22M | 18.50M | 9.79M | -10.01M |
| Total Depreciation and Amortization | 3.04M | 2.48M | 1.85M | 1.38M | 839.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 30.67M | 28.37M | 26.26M | 30.29M | 22.98M |
| Change in Net Operating Assets | -43.41M | 3.11M | 5.68M | -41.54M | -4.95M |
| Cash from Operations | -6.70M | 69.18M | 52.28M | -78.00K | 8.86M |
| Capital Expenditure | -8.41M | -7.03M | -8.01M | -12.39M | -11.70M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 6.85M | 10.79M | -94.96M | 18.01M | -7.84M |
| Cash from Investing | -1.55M | 3.76M | -102.97M | 5.62M | -19.54M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 6.44M | 982.00K | 14.23M | 8.95M | 3.62M |
| Repurchase of Common Stock | -94.20M | -71.12M | -4.34M | -1.86M | -2.85M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -87.76M | -70.14M | 9.89M | 7.09M | 768.00K |
| Foreign Exchange rate Adjustments | -252.00K | -166.00K | 272.00K | -10.00K | -214.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -96.27M | 2.64M | -40.52M | 12.62M | -10.12M |